Eli Lilly and Company
PRESERVED FORMULATIONS
Last updated:
Abstract:
The present invention relates to preserved, surfactant-containing pharmaceutical compositions that are suitable for parenteral administration.
Status:
Application
Type:
Utility
Filling date:
11 Mar 2020
Issue date:
12 May 2022